Compare OTEX & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTEX | DVA |
|---|---|---|
| Founded | 1991 | 1994 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.2B |
| IPO Year | 1998 | 1995 |
| Metric | OTEX | DVA |
|---|---|---|
| Price | $30.96 | $105.89 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $39.30 | ★ $145.00 |
| AVG Volume (30 Days) | 662.9K | ★ 794.8K |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 10.23 | 5.63 |
| EPS | 1.91 | ★ 9.76 |
| Revenue | $5,187,535,000.00 | ★ $13,317,965,000.00 |
| Revenue This Year | $2.76 | $6.50 |
| Revenue Next Year | $1.81 | $2.97 |
| P/E Ratio | $16.77 | ★ $10.64 |
| Revenue Growth | N/A | ★ 5.14 |
| 52 Week Low | $22.79 | $101.00 |
| 52 Week High | $39.90 | $179.60 |
| Indicator | OTEX | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 31.79 | 30.49 |
| Support Level | $31.92 | $101.00 |
| Resistance Level | $33.69 | $113.51 |
| Average True Range (ATR) | 0.79 | 2.97 |
| MACD | -0.05 | -0.82 |
| Stochastic Oscillator | 3.15 | 31.82 |
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.